HOPE - A Study to Evaluate the Effect of a Prehabilitation Program on GI Cancer Patients Planning to Undergo Surgery

NCT ID: NCT03642093

Last Updated: 2018-09-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-08-01

Study Completion Date

2019-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A one-group prospective cohort study design with measures collected pre- and post-intervention. The primary goal of this study is to evaluate the effect of a multimodal prehabilitation preoperative program on changes in frailty in upper gastrointestinal surgical oncology patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cancer patients often develop protein calorie malnutrition, inflammatory states, and loss of lean muscle mass, which can be best categorized as frailty. Frailty affects global health, the ability to carry out normal functions, and even the ability to tolerate targeted curative treatments such as surgery, chemotherapy, and radiation. The Investigators evaluate frailty, and design a study to evaluate the outcomes of the administration of multimodal preoperative prehabilitation programs on those frailty markers. Previous data provides support for interventions that include:

1. Improved protein rich nutrition with specific immunonutrition recommendations,
2. Treatment of maldigestion or pancreatic insufficiency in pancreatic, gastric, or esophageal cancer patients,
3. Brief, evidence-based activity interventions such as walking and inspiratory muscle training (IMT), and
4. Disease specific education

These interventions should improve frailty by maintaining or regaining weight, improved grip strength, and improved prealbumin. These markers indicate improvements in nutritional status, increased strength and ability to ambulate, and improved functional status in the preoperative period. Other outcomes that will be reported include fat-soluble vitamin levels, global health, and inflammation.

The preoperative period is the best time to facilitate patient engagement through self-care and proactive activity. Interventions must be easy to accomplish and structured so patients have accountability and both patients and clinicians have methods and tools for measuring progress. Most patients and family members are motivated at this time and understand the need to improve frailty and potentially improve global health.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pancreatic Cancer Esophageal Cancer Gastric Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Frail

Subjects assessed and determined to be Frail and meet trial eligibility criteria will be enrolled on Frail Arm and begin a 4 Week program consisting of Nutritional Interventions and Physical Activity Interventions

Group Type EXPERIMENTAL

Nutritional Intervention

Intervention Type COMBINATION_PRODUCT

Nutritional Supplementation for all subjects and Pancreatic Enzyme Replacement Therapy only for subjects with Exocrine Pancreatic Insufficiency

Physical Activity Intervention

Intervention Type BEHAVIORAL

Walking and Inspiratory Muscle Training

Not Frail

Subjects assessed and determined to be Not Frail and meet trial eligibility criteria will be enrolled on Not Frail Arm and begin a 4 Week program consisting of Nutritional Interventions and Physical Activity Interventions

Group Type ACTIVE_COMPARATOR

Nutritional Intervention

Intervention Type COMBINATION_PRODUCT

Nutritional Supplementation for all subjects and Pancreatic Enzyme Replacement Therapy only for subjects with Exocrine Pancreatic Insufficiency

Physical Activity Intervention

Intervention Type BEHAVIORAL

Walking and Inspiratory Muscle Training

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nutritional Intervention

Nutritional Supplementation for all subjects and Pancreatic Enzyme Replacement Therapy only for subjects with Exocrine Pancreatic Insufficiency

Intervention Type COMBINATION_PRODUCT

Physical Activity Intervention

Walking and Inspiratory Muscle Training

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Immunonutrition

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients must be patients of Ochsner being seen at the Ochsner Medical Center (OMC).
* All patients must be 25 to 80 years of age.
* All patients must have a diagnosis of cancer.
* \> 10 pound unintentional weight loss within 1 year
* Ability to perform grip strength test and Timed Up and Go (TUG) test
* Willingness to participate in the study, document compliance, and attend clinical appointments
* All patients must be undergoing one of the following major elective surgical oncologic resections with curative intent:

* Pancreaticoduodenectomy for pancreatic cancer
* Distal pancreatectomy / splenectomy for pancreatic cancer
* Esophageal robotic assisted laparoscopic thoracoscopic esophagectomy for esophageal cancer
* Laparoscopic or open, partial or total gastrectomy for gastric cancer

Exclusion Criteria

* All patients not undergoing oncologic or major resections.
* All patients unwilling or unable to answer questionnaires or accept help to answer electronic or paper questionnaires.
* All patients that are unable to participate in an activity program.
* All patients unable to wear an electronic activity monitoring device.
* All patients not wanting to follow a specific nutritional and breathing intervention.
* All patients that are not able or wishing to consent.
Minimum Eligible Age

25 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Siobhan Trotter

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Siobhan Trotter

Nurse Practitioner, Preoperative Optimization Program, Surgical Oncology and General Surgery

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Siobhan M Trotter, DNP

Role: PRINCIPAL_INVESTIGATOR

Ochsner Health System

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ochsner Medical Center

New Orleans, Louisiana, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HOPE Study 2018.045

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.